Epkinly (Epcoritamab-bysp)
- Medicine Name: Epkinly
- Generic Name: Epcoritamab-bysp
- Dosage Form & Strength: Injection: 4 mg/0.8 mL and 48 mg/0.8 mL
- Manufactured By: Genmab and AbbVie Inc.
- Epkinly injection can cause CRS, including critical or severe reactions. Those who experience CRS (or other side effects that can impair consciousness) need to be assessed. Patients should avoid driving and refrain from operating machinery until resolution.
- Epcoritamab can be responsible for causing critical/severe and fatal immune effector cell-related neurotoxicity syndrome (ICANS). Evaluate patients for potential ICANS after Epkinly treatment. At the initial signs or symptoms of ICANS, promptly assess patients and provide relevant therapy on behalf of severity.
- Epkinly therapy can cause critical and fatal infections. Assess patients for signs and symptoms of infection before and throughout treatment with this medication and treat as required. Avoid the use of this medicinal product in those with active infections.
- Epkinly 4 mg/0.8 mL or 48 mg/0.8 mL can cause severe cytopenias, including thrombocytopenia, neutropenia, and anemia. Monitor complete blood counts (CBC) throughout treatment. Based on the seriousness of cytopenias, temporarily interrupt or permanently discontinue treatment.
- As per the mechanism of action, Epkinly may cause fetal harm if used by a pregnant woman. Advise such females of the probable risk to the fetus. Females of reproductive age should use effective contraception during therapy and for 4 months following the final dose
What documents are required to import EPKINLY to India?
EPKINLY (epcoritamab-bysp) injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
EPKINLY (epcoritamab injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input:
- On availability of Epkinly in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
IPN (Indian Pharma Network) can facilitate the supply of EPKINLY (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Epkinly price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the EPKINLY (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Epkinly®?
Epcoritamab-bysp is a Generic Name for the trade name drug Epkinly®.
What is the Manufacturer’s Name of Epkinly®?
Epkinly® is manufactured by Genmab and AbbVie Inc.
Is Epkinly® approved by the FDA?
Yes, Epkinly® is approved by the FDA. Date of first approval: May 19, 2023.
Where can I get Epkinly® at the best price in India?
To get the best Epkinly injection price in India, kindly connect with the Indian Pharma Network (a WHO GDP & ISO 9001:2008 certified company). For Epkinly®, a valid medical prescription is required from a treating physician.
What is the dosage and form of Epkinly® supplied?
Epkinly® is supplied as Injections: 4 mg/0.8 mL and 48 mg/0.8 mL in a single-dose vial for subcutaneous use/administration.
What are the most common side effects of Epkinly®?
The most common side effects of Epkinly® are fatigue, cytokine release syndrome, musculoskeletal pain, abdominal pain, injection site reactions, pyrexia, diarrhea, and nausea.
How much does Epkinly® cost in India?
The cost of Epkinly in India can vary. In order to procure this medicine legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Epkinly®?
Store refrigerated at 2-8°C (36-46°F). Keep the medicine in the original carton to protect it from light. It is not advisable to freeze and shake it.
Is it safe to buy Epkinly® online in India?
Yes, one can buy Epkinly online in India at the lowest price from the Indian Pharma Network (IPN) if the medicine Epkinly® is not (yet) registered or available in your country. We can help facilitate the supply of Epkinly® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.